Testing effectiveness (Phase 2)Study completedNCT03157037
What this trial is testing
Open-Label Phase II Study to Evaluate the Efficacy and Safety of IdeS in Anti-GBM Disease
Who this might be right for
Anti-Glomerular Basement Membrane Antibody Disease
Mårten Segelmark 15